A multicentre, randomised, double-bllind, placebo- and active-controlled, phase 3 study to evaluate the efficacy and safety of TAK-875 25 mg and 50 mg compared to placebo and Sitagliptin 100mg

Project: Research

StatusFinished
Effective start/end date24/09/1231/05/16